About
Our Science
News
Contact Us
About
Our Science
News
Contact Us
News & Resources
MEDIA COVERAGE
Press Releases
Articles
PRESENTATIONS
Events
View All
Press Release
Mar 1, 2022 | ProJenX
ProJenX Announces First Person Dosed in Phase 1 Study of Prosetin
Read More
Press Release
Feb 16, 2022 | ProJenX
ProJenX Launches to Advance Novel, Targeted Therapies for ALS and Other Brain Diseases
Read More
Article
Nov 16, 2019 | Cell Press
Development of MAP4 Kinase Inhibitors as Motor Neuron-Protecting Agents
Read More
Article
Jan 16, 2019 | The American Society of Gene and Cell Therapy
A Stem Cell-Based Screening Platform Identifies Compounds…
Read More
Previous Page
Contact Us to Learn More About Our Fight Against ALS
Contact Us